학술논문

Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD.
Document Type
Article
Source
European Respiratory Review; Mar2023, Vol. 32 Issue 167, p1-20, 20p
Subject
INTERLEUKIN-33
THERAPEUTICS
CHRONIC obstructive pulmonary disease
HEALTH outcome assessment
PUBLIC health
ASTHMA
Language
ISSN
09059180
Abstract
Copyright of European Respiratory Review is the property of European Respiratory Society and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)